163 related articles for article (PubMed ID: 18394172)
21. The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.
Molyneux G; Smalley MJ
J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):51-5. PubMed ID: 21336547
[TBL] [Abstract][Full Text] [Related]
22. Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.
Warmoes M; Jaspers JE; Pham TV; Piersma SR; Oudgenoeg G; Massink MP; Waisfisz Q; Rottenberg S; Boven E; Jonkers J; Jimenez CR
Mol Cell Proteomics; 2012 Jul; 11(7):M111.013334. PubMed ID: 22366898
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells.
Vassilopoulos A; Wang RH; Petrovas C; Ambrozak D; Koup R; Deng CX
Int J Biol Sci; 2008 May; 4(3):133-42. PubMed ID: 18461147
[TBL] [Abstract][Full Text] [Related]
24. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
25. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Herschkowitz JI; Simin K; Weigman VJ; Mikaelian I; Usary J; Hu Z; Rasmussen KE; Jones LP; Assefnia S; Chandrasekharan S; Backlund MG; Yin Y; Khramtsov AI; Bastein R; Quackenbush J; Glazer RI; Brown PH; Green JE; Kopelovich L; Furth PA; Palazzo JP; Olopade OI; Bernard PS; Churchill GA; Van Dyke T; Perou CM
Genome Biol; 2007; 8(5):R76. PubMed ID: 17493263
[TBL] [Abstract][Full Text] [Related]
26. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
27. Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
Hoshino A; Yee CJ; Campbell M; Woltjer RL; Townsend RL; van der Meer R; Shyr Y; Holt JT; Moses HL; Jensen RA
Int J Biol Sci; 2007 Apr; 3(5):281-91. PubMed ID: 17505536
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model.
Franci C; Zhou J; Jiang Z; Modrusan Z; Good Z; Jackson E; Kouros-Mehr H
PLoS One; 2013; 8(3):e58183. PubMed ID: 23520493
[TBL] [Abstract][Full Text] [Related]
29. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
30. Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors.
Bach K; Pensa S; Zarocsinceva M; Kania K; Stockis J; Pinaud S; Lazarus KA; Shehata M; Simões BM; Greenhalgh AR; Howell SJ; Clarke RB; Caldas C; Halim TYF; Marioni JC; Khaled WT
Nat Commun; 2021 Mar; 12(1):1502. PubMed ID: 33686070
[TBL] [Abstract][Full Text] [Related]
31. Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer.
Ratz L; Brambillasca C; Bartke L; Huetzen MA; Goergens J; Leidecker O; Jachimowicz RD; van de Ven M; Proost N; Siteur B; de Korte-Grimmerink R; Bouwman P; Pulver EM; de Bruijn R; Isensee J; Hucho T; Pandey G; van Lohuizen M; Mallmann P; Reinhardt HC; Jonkers J; Puppe J
Breast Cancer Res; 2022 Jun; 24(1):41. PubMed ID: 35715861
[TBL] [Abstract][Full Text] [Related]
32. Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-Ras.
Navaraj A; Finnberg N; Dicker DT; Yang W; Matthew EM; El-Deiry WS
Cancer Biol Ther; 2009 Dec; 8(24):2417-44. PubMed ID: 20038817
[TBL] [Abstract][Full Text] [Related]
33. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice.
Lanza DG; Ma J; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
Tumour Biol; 2012 Dec; 33(6):1997-2005. PubMed ID: 22836804
[TBL] [Abstract][Full Text] [Related]
35. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
Bai F; Wang C; Liu X; Hollern D; Liu S; Fan C; Liu C; Ren S; Herschkowitz JI; Zhu WG; Pei XH
Cell Death Dis; 2022 Mar; 13(3):195. PubMed ID: 35236825
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms and protein expression of P53 and BRCA1 in preneoplastic and neoplastic rat mammary glands.
Al-Dhaheri W; Hassouna I; Karam SM
Oncol Rep; 2018 May; 39(5):2193-2200. PubMed ID: 29498408
[TBL] [Abstract][Full Text] [Related]
37. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
38. Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.
Rottenberg S; Vollebergh MA; de Hoon B; de Ronde J; Schouten PC; Kersbergen A; Zander SA; Pajic M; Jaspers JE; Jonkers M; Lodén M; Sol W; van der Burg E; Wesseling J; Gillet JP; Gottesman MM; Gribnau J; Wessels L; Linn SC; Jonkers J; Borst P
Cancer Res; 2012 May; 72(9):2350-61. PubMed ID: 22396490
[TBL] [Abstract][Full Text] [Related]
39. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
40. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
Moynahan ME
Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
